EBP50 promotes focal adhesion turnover and vascular smooth muscle cells migration

Journal of Molecular and Cellular Cardiology

Volumn 53, Issue 6, 2012, Pages 809-819

  Song, Gyun Jee ^a   Leslie, Kristen L ^a   Barrick, Stacey ^a   Bougoin, Sylvain ^b   Taboas, Juan M ^b   Bisello, Alessandro ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

EBP50; FAK; Focal adhesion; Migration; NHERF; Vascular smooth muscle cell

Indexed keywords

EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EZRIN RADIXIN MOESIN BINDING PHOSPHOPROTEIN 50; FOCAL ADHESION KINASE; PDZ PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CELL ISOLATION; CELL MIGRATION; CELL MOTILITY; CELL SPREADING; CONTROLLED STUDY; ENZYME ACTIVATION; FLUORESCENCE ANALYSIS; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; FOCAL ADHESION; IMMUNOPRECIPITATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; WILD TYPE;

ANIMALS; BLOOD VESSELS; CELL LINE; CELL MOVEMENT; EPIDERMAL GROWTH FACTOR; FOCAL ADHESION KINASE 1; FOCAL ADHESIONS; MICE; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN BINDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; SODIUM-HYDROGEN ANTIPORTER;

MUS;

EID: 84869093742     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.08.022     Document Type: Article

References (51)

1. Aman A., Piotrowski T. Cell migration during morphogenesis. Dev Biol 2010, 341:20-33.
2. Friedl P., Gilmour D. Collective cell migration in morphogenesis, regeneration and cancer. Nat Rev Mol Cell Biol 2009, 10:445-457.
3. Sanz-Moreno V., Marshall C.J. The plasticity of cytoskeletal dynamics underlying neoplastic cell migration. Curr Opin Cell Biol 2010, 22:690-696.
4. Makrilia N., Kollias A., Manolopoulos L., Syrigos K. Cell adhesion molecules: role and clinical significance in cancer. Cancer Invest 2009, 27:1023-1037.
5. Louis S.F., Zahradka P. Vascular smooth muscle cell motility: from migration to invasion. Exp Clin Cardiol 2010, 15:e75-e85.
6. Gerthoffer W.T. Mechanisms of vascular smooth muscle cell migration. Circ Res 2007, 100:607-621.
7. Romer L.H., Birukov K.G., Garcia J.G. Focal adhesions: paradigm for a signaling nexus. Circ Res 2006, 98:606-616.
8. Webb D.J., Donais K., Whitmore L.A., Thomas S.M., Turner C.E., Parsons J.T., et al. FAK-Src signalling through paxillin, ERK and MLCK regulates adhesion disassembly. Nat Cell Biol 2004, 6:154-161.
9. Iwanicki M.P., Vomastek T., Tilghman R.W., Martin K.H., Banerjee J., Wedegaertner P.B., et al. FAK, PDZ-RhoGEF and ROCKII cooperate to regulate adhesion movement and trailing-edge retraction in fibroblasts. J Cell Sci 2008, 121:895-905.
10. Zaidel-Bar R., Itzkovitz S., Ma'ayan A., Iyengar R., Geiger B Functional atlas of the integrin adhesome. Nat Cell Biol 2007, 9:858-867.
11. Schober M., Raghavan S., Nikolova M., Polak L., Pasolli H.A., Beggs H.E., et al. Focal adhesion kinase modulates tension signaling to control actin and focal adhesion dynamics. J Cell Biol 2007, 176:667-680.
12. Sieg D.J., Hauck C.R., Ilic D., Klingbeil C.K., Schaefer E., Damsky C.H., et al. FAK integrates growth-factor and integrin signals to promote cell migration. Nat Cell Biol 2000, 2:249-256.
13. Gilmore A.P., Romer L.H. Inhibition of focal adhesion kinase (FAK) signaling in focal adhesions decreases cell motility and proliferation. Mol Biol Cell 1996, 7:1209-1224.
14. Sieg D.J., Hauck C.R., Schlaepfer D.D. Required role of focal adhesion kinase (FAK) for integrin-stimulated cell migration. J Cell Sci 1999, 112:2677-2691.
15. Ilic D., Furuta Y., Kanazawa S., Takeda N., Sobue K., Nakatsuji N., et al. Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice. Nature 1995, 377:539-544.
16. Schaller M.D., Hildebrand J.D., Shannon J.D., Fox J.W., Vines R.R., Parsons J.T. Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src. Mol Cell Biol 1994, 14:1680-1688.
17. Calalb M.B., Polte T.R., Hanks S.K. Tyrosine phosphorylation of focal adhesion kinase at sites in the catalytic domain regulates kinase activity: a role for Src family kinases. Mol Cell Biol 1995, 15:954-963.
18. Schlaepfer D.D., Hunter T. Evidence for in vivo phosphorylation of the Grb2 SH2-domain binding site on focal adhesion kinase by Src-family protein-tyrosine kinases. Mol Cell Biol 1996, 16:5623-5633.
19. Deramaudt T.B., Dujardin D., Hamadi A., Noulet F., Kolli K., De Mey J., et al. FAK phosphorylation at Tyr-925 regulates cross-talk between focal adhesion turnover and cell protrusion. Mol Biol Cell 2011, 22:964-975.
20. Romero G., von Zastrow M., Friedman P.A. Role of PDZ proteins in regulating trafficking, signaling, and function of GPCRs: means, motif, and opportunity. Adv Pharmacol 2011, 62:279-314.
21. Weinman E.J., Steplock D., Wang Y., Shenolikar S. Characterization of a protein cofactor that mediates protein kinase A regulation of the renal brush border membrane Na(+)-H(+) exchanger. J Clin Invest 1995, 95:2143-2149.
22. Seidler U., Singh A.K., Cinar A., Chen M., Hillesheim J., Hogema B., et al. The role of the NHERF family of PDZ scaffolding proteins in the regulation of salt and water transport. Ann N Y Acad Sci 2009, 1165:249-260.
23. Blaine J., Weinman E.J., Cunningham R. The regulation of renal phosphate transport. Adv Chronic Kidney Dis 2011, 18:77-84.
24. Kato A., Romero M.F. Regulation of electroneutral NaCl absorption by the small intestine. Annu Rev Physiol 2011, 73:261-281.
25. Fouassier L., Rosenberg P., Mergey M., Saubamea B., Claperon A., Kinnman N., et al. Ezrin-radixin-moesin-binding phosphoprotein (EBP50), an estrogen-inducible scaffold protein, contributes to biliary epithelial cell proliferation. Am J Pathol 2009, 174:869-880.
26. Li M., Wang W., Soroka C.J., Mennone A., Harry K., Weinman E.J., et al. NHERF-1 binds to Mrp2 and regulates hepatic Mrp2 expression and function. J Biol Chem 2010, 285:19299-19307.
27. Song J., Bai J., Yang W., Gabrielson E.W., Chan D.W., Zhang Z. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. Histopathology 2007, 51:40-53.
28. Shibata T., Chuma M., Kokubu A., Sakamoto M., Hirohashi S. EBP50, a beta-catenin-associating protein, enhances Wnt signaling and is over-expressed in hepatocellular carcinoma. Hepatology 2003, 38:178-186.
29. Kislin K.L., McDonough W.S., Eschbacher J.M., Armstrong B.A., Berens M.E. NHERF-1: modulator of glioblastoma cell migration and invasion. Neoplasia 2009, 11:377-387.
30. Hayashi Y., Molina J.R., Hamilton S.R., Georgescu M.M. NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia 2010, 12:1013-1022.
31. Baeyens N., Horman S., Vertommen D., Rider M., Morel N. Identification and functional implication of a Rho kinase-dependent moesin-EBP50 interaction in noradrenaline-stimulated artery. Am J Physiol Cell Physiol 2010, 299:C1530-C1540.
32. Song G.J., Barrick S., Leslie K.L., Sicari B., Fiaschi-Taesch N.M., Bisello A. EBP50 inhibits the anti-mitogenic action of the parathyroid hormone type 1 receptor in vascular smooth muscle cells. J Mol Cell Cardiol 2010, 49:1012-1021.
33. Song G.J., Barrick S., Leslie K.L., Bauer P.M., Alonso V., Friedman P.A., et al. The scaffolding protein EBP50 promotes vascular smooth muscle cell proliferation and neointima formation by regulating Skp2 and p21(cip1). Arterioscler Thromb Vasc Biol 2012, 32:33-41.
34. Bolte S., Cordelieres F.P. A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 2006, 224:213-232.
35. James M.F., Beauchamp R.L., Manchanda N., Kazlauskas A., Ramesh V. A NHERF binding site links the betaPDGFR to the cytoskeleton and regulates cell spreading and migration. J Cell Sci 2004, 117:2951-2961.
36. Lazar C.S., Cresson C.M., Lauffenburger D.A., Gill G.N. The Na+/H+ exchanger regulatory factor stabilizes epidermal growth factor receptors at the cell surface. Mol Biol Cell 2004, 15:5470-5480.
37. Hayashi Y., Molina J.R., Hamilton S.R., Georgescu M.M. NHERF1/EBP50 is a new marker in colorectal cancer. Neoplasia 2010, 12:1013-1022.
38. Takahashi Y., Morales F.C., Kreimann E.L., Georgescu M.M. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 2006, 25:910-920.
39. Baeyens N., de Meester C., Yerna X., Morel N. EBP50 is involved in the regulation of vascular smooth muscle cell migration and cytokinesis. J Cell Biochem 2011, 112:2574-2584.
40. Hall R.A., Spurney R.F., Premont R.T., Rahman N., Blitzer J.T., Pitcher J.A., et al. G protein-coupled receptor kinase 6A phosphorylates the Na(+)/H(+) exchanger regulatory factor via a PDZ domain-mediated interaction. J Biol Chem 1999, 274:24328-24334.
41. Voltz J.W., Brush M., Sikes S., Steplock D., Weinman E.J., Shenolikar S. Phosphorylation of PDZ1 domain attenuates NHERF-1 binding to cellular targets. J Biol Chem 2007, 282:33879-33887.
42. Weinman E.J., Steplock D., Zhang Y., Biswas R., Bloch R.J., Shenolikar S. Cooperativity between the phosphorylation of Thr95 and Ser77 of NHERF-1 in the hormonal regulation of renal phosphate transport. J Biol Chem 2010, 285:25134-25138.
43. Fouassier L., Nichols M.T., Gidey E., McWilliams R.R., Robin H., Finnigan C., et al. Protein kinase C regulates the phosphorylation and oligomerization of ERM binding phosphoprotein 50. Exp Cell Res 2005, 306:264-273.
44. Li J., Poulikakos P.I., Dai Z., Testa J.R., Callaway D.J., Bu Z. Protein kinase C phosphorylation disrupts Na+/H+ exchanger regulatory factor 1 autoinhibition and promotes cystic fibrosis transmembrane conductance regulator macromolecular assembly. J Biol Chem 2007, 282:27086-27099.
45. Raghuram V., Hormuth H., Foskett J.K. A kinase-regulated mechanism controls CFTR channel gating by disrupting bivalent PDZ domain interactions. Proc Natl Acad Sci U S A 2003, 100:9620-9625.
46. Morales F.C., Takahashi Y., Momin S., Adams H., Chen X., Georgescu M.M. NHERF1/EBP50 head-to-tail intramolecular interaction masks association with PDZ domain ligands. Mol Cell Biol 2007, 27:2527-2537.
47. Reczek D., Bretscher A. The carboxyl-terminal region of EBP50 binds to a site in the amino-terminal domain of ezrin that is masked in the dormant molecule. J Biol Chem 1998, 273:18452-18458.
48. Li J., Callaway D.J., Bu Z. Ezrin induces long-range interdomain allostery in the scaffolding protein NHERF1. J Mol Biol 2009, 392:166-180.
49. Li J., Dai Z., Jana D., Callaway D.J., Bu Z. Ezrin controls the macromolecular complexes formed between an adapter protein Na+/H+ exchanger regulatory factor and the cystic fibrosis transmembrane conductance regulator. J Biol Chem 2005, 280:37634-37643.
50. Cardone R.A., Bellizzi A., Busco G., Weinman E.J., Dell'Aquila M.E., Casavola V., et al. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 2007, 18:1768-1780.
51. Ardura J.A., Friedman P.A. Regulation of G protein-coupled receptor function by Na+/H+ exchange regulatory factors. Pharmacol Rev 2011, 63:882-900.